HighCape Capital, LLC, Ten Percent Owner at Aziyo Biologics, holds 9.10M shares in Aziyo Biologics (Ticker: ELUT). Most recently, HighCape Capital, LLC Bought $2,101,577 shares of Aziyo Biologics on Aug 01, 2024 for an estimated value of 2.98M.
What is the percentage of profitable transactions made by HighCape Capital, LLC?
The percentage of profitable transactions made by HighCape Capital, LLC is ―.
What is the average return per transaction made by HighCape Capital, LLC?
The average return per transaction made by HighCape Capital, LLC is ―.
What stocks does HighCape Capital, LLC hold?
HighCape Capital, LLC holds: ELUT stocks.
What was HighCape Capital, LLC’s latest transaction?
HighCape Capital, LLC latest transaction was an Informative Buy of $2.98M.
What was HighCape Capital, LLC's most profitable transaction?
HighCape Capital, LLC’s most profitable transaction was an Informative Buy of ELUT stock on August 1, 2024. The return on the trade was 7.00%.
What is HighCape Capital, LLC's role in Aziyo Biologics?
HighCape Capital, LLC's role in Aziyo Biologics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.